Author Correction: Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial
Year: 2026
Type: erratum
Abstract: In the version of the article initially published, among the SYNCHRONIZE-MASLD Investigators, Juan M. Pericás (Liver Unit, Vall d’Hebron University Hospital, VHIR, Universitat Autònoma de Barcelona, CIBERehd, Barcelona, Spain) and Michael Zimmerman (Velocity Clinical Research, Austin, TX, USA) were not included in the author list; Antonio Olveira (Hospital Universitario La Paz, Madrid, Spain) was listed with an incorrect surname (Antonio O. Martin) and an incorrect additional affiliation; and Rizwana Mohseni was listed with an incorrect second affiliation. In the “Participants” section of Results, there was a typographical error: in the sentence now reading “Treatment discontinuation occurred at a similar frequency in the survodutide (41.1% (60/146)) and placebo (40.0% (28/70)) arms,” “70” originally appeared as “72.” Additionally, in the caption to Extended Data Fig. 5, “week 52” now replaces the original “week 48.” The changes have been made in the HTML and PDF versions of the article.
Source: Nature Medicine
Authors: Lee M. Kaplan, Elena Startseva, Carel W. le Roux, Sean Wharton, Biykem Bozkurt, Daniel F. Mazo, Jessica von Schlippenbach, Sandra González Maldonado, Samina Ajaz Hussain, Guy W. Neff, Yaneicy Gonzalez Rojas, Charles Smith, Ramy Younes, Arun J. Sanyal, on behalf of the SYNCHRONIZE-MASLD Investigators, Antonio Olveira, Juan M. Pericás, Mark Leibowitz, Douglas Denham, Kevin Korenblat, Michael Herman, Shekhar Challa, Rasha Youssef, Masi Khaja, Apinya Vutikullird, Humberto Aguilar, Naga Chalasani, James Maher, Ronald Surowitz, Cassandra Steimle, Yaneicy G. Rojas, Antonio Sanchez, Ruth E. Kavcioglu, Julio Vijil, Robert Perry, Guy Neff, Martha G. Navarro, Omer Khalid, Rizwana Mohseni, Michael Zimmerman, Julie Vu, Gregg Lucksinger, Satish Iduru, Dmitry Shuster, Bruce Segal, Paul Hellstern
Institutions: Dartmouth College, Boehringer Ingelheim (Germany), University College Dublin, University of Ulster, University of Toronto, McMaster University, Baylor College of Medicine, Virginia Commonwealth University, Virginia Commonwealth University Medical Center, Hospital Universitario La Paz, Universitat Autònoma de Barcelona, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Velocity Clinical Research (United States), Clinical Trials of Texas, Washington University in St. Louis, Fleming Island Center For Clinical Research, Indiana University Indianapolis, Health Awareness (United States), University of Iowa Health Care, Catalina Research Institute, Accurate Clinical Research (United States), Springfield Clinic
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $12,690
OpenAlex ID: W7204172485